POSC279 The Impact of a Reassessment Due to New Scientific Findings on the Additional Benefit and on the Reimbursed Price of Pharmaceutical Products According to §35A Sgb V in Germany
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.916
https://www.valueinhealthjournal.com/article/S1098-3015(21)02711-X/fulltext
Title :
POSC279 The Impact of a Reassessment Due to New Scientific Findings on the Additional Benefit and on the Reimbursed Price of Pharmaceutical Products According to §35A Sgb V in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02711-X&doi=10.1016/j.jval.2021.11.916
First page :
Section Title :
Open access? :
No
Section Order :
10445